BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10365730)

  • 61. [Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells].
    Morozov IA
    Eksp Klin Gastroenterol; 2002; (3):94-100, 122. PubMed ID: 12353402
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
    Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative study and optimisation of the administration mode of three proton pump inhibitors by nasogastric tube.
    Messaouik D; Sautou-Miranda V; Bagel-Boithias S; Chopineau J
    Int J Pharm; 2005 Aug; 299(1-2):65-72. PubMed ID: 15990258
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of hyphal growth of Candida albicans by activated lansoprazole, a novel benzimidazole proton pump inhibitor.
    Biswas SK; Yokoyama K; Kamei K; Nishimura K; Miyaji M
    Med Mycol; 2001 Jun; 39(3):283-5. PubMed ID: 11446532
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anodic voltammetric assay of lansoprazole and omeprazole on a carbon paste electrode.
    Radi A
    J Pharm Biomed Anal; 2003 Apr; 31(5):1007-12. PubMed ID: 12684113
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Myoclonic encephalopathy associated with proton pump inhibitors].
    Boulliat J; Polard E; Colin F; Bentué-Ferrer D; Allain H
    Rev Neurol (Paris); 2004 Mar; 160(3):350-1. PubMed ID: 15037850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Galactorrhea induced by lansoprazole].
    Izquierdo Prieto OM; Moreno Alía E; Rosillo González A
    Aten Primaria; 2004 Oct; 34(6):325-6. PubMed ID: 15491529
    [No Abstract]   [Full Text] [Related]  

  • 72. Tetany secondary to the use of a proton-pump inhibitor.
    Subbiah V; Tayek JA
    Ann Intern Med; 2002 Aug; 137(3):219. PubMed ID: 12160379
    [No Abstract]   [Full Text] [Related]  

  • 73. Acido-basic properties of proton pump inhibitors in aqueous solutions.
    Kristl A
    Drug Dev Ind Pharm; 2009 Jan; 35(1):114-7. PubMed ID: 18720145
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Activation and stabilization of drugs by supramolecular pKa shifts: drug-delivery applications tailored for cucurbiturils.
    Saleh N; Koner AL; Nau WM
    Angew Chem Int Ed Engl; 2008; 47(29):5398-401. PubMed ID: 18548429
    [No Abstract]   [Full Text] [Related]  

  • 75. Proton pump inhibitors: Weighing the benefits and risks across various health conditions.
    Sizgoric L; Likic R
    Br J Clin Pharmacol; 2024 Feb; 90(2):388-391. PubMed ID: 38013514
    [No Abstract]   [Full Text] [Related]  

  • 76. Delivery of esomeprazole magnesium enteric-coated pellets through small caliber and standard nasogastric tubes and gastrostomy tubes in vitro.
    White CM; Kalus JS; Quercia R; Fortier C; Piotrowski A; Roach A; Sostek MB
    Am J Health Syst Pharm; 2002 Nov; 59(21):2085-8. PubMed ID: 12434721
    [No Abstract]   [Full Text] [Related]  

  • 77. New way to stabilize nasogastric tubes.
    Sader AA
    Am J Surg; 1975 Jul; 130(1):102. PubMed ID: 1155710
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insertion of nasogastric tubes.
    Van der Weyden C
    Br J Anaesth; 1979 Jan; 51(1):73. PubMed ID: 552288
    [No Abstract]   [Full Text] [Related]  

  • 79. Method for anchoring nasogastric feeding tubes.
    Rajaratnam R
    Laryngoscope; 1985 Feb; 95(2):219-20. PubMed ID: 3968958
    [No Abstract]   [Full Text] [Related]  

  • 80. 10 problems with nasogastric tubes--and how to solve them.
    McConnell EA
    Nursing; 1979 Apr; 9(4):78-81. PubMed ID: 253949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.